Sleep Europe 2024 | Incorporating new developments in RLS into clinical guidelines

Samson Khachatryan, MD, PhD, National Institute of Health of Armenia, Yerevan, Armenia, discusses the widespread prevalence of restless legs syndrome (RLS) in Western countries, highlighting its impact on sleep and overall quality of life. Dr Khachatryan explains that treatments for RLS, such as dopaminergic drugs, gabapentinoids, and iron therapy, are being refined as research advances, though the precise pathophysiology of the disorder remains unclear. Additionally, updates to RLS guidelines are underway in Europe and the United States to incorporate the most recent findings. This interview took place at the Sleep Europe 2024 congress in Seville, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.